Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aflibercept With Adjuvant Micro-Pulsed Yellow Laser in DME
NCT03866746Phase 4Completed
- Sponsor
- Al Hadi Hospital
- Start
- May 2017
- Primary completion
- Jun 2017
- Modality
- Engineered Antibody Formats, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 4 trial of aflibercept in diabetic macular edema (DME), sponsored by Al Hadi Hospital. Started May 2017; status: completed.
02
Drugs
aflibercept
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT03866746.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03866746.